PlainRecalls
FDA Drug Low Class III Terminated

Alprostadil Injection USP 500 mcg/mL, 1 mL Single Dose Vial, 5 vials per Carton, Rx Only, Carton NDC 0703-1501-02, Distributed by: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054, Vial NDC 0703-1501-01

Reported: June 15, 2022 Initiated: May 18, 2022 #D-0988-2022

Product Description

Alprostadil Injection USP 500 mcg/mL, 1 mL Single Dose Vial, 5 vials per Carton, Rx Only, Carton NDC 0703-1501-02, Distributed by: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054, Vial NDC 0703-1501-01

Reason for Recall

Failed Impurities/Degradation Specifications; out-of-specification results for impurities obtained during routine stability testing

Details

Units Affected
3109 cartons
Distribution
Product was distributed nationwide in the US Market
Location
Parsippany, NJ

Frequently Asked Questions

What product was recalled?
Alprostadil Injection USP 500 mcg/mL, 1 mL Single Dose Vial, 5 vials per Carton, Rx Only, Carton NDC 0703-1501-02, Distributed by: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054, Vial NDC 0703-1501-01. Recalled by Teva Pharmaceuticals USA Inc. Units affected: 3109 cartons.
Why was this product recalled?
Failed Impurities/Degradation Specifications; out-of-specification results for impurities obtained during routine stability testing
Which agency issued this recall?
This recall was issued by the FDA Drug on June 15, 2022. Severity: Low. Recall number: D-0988-2022.